Generic
Tranexamic Acid

Description
Tracid 500 is a 500 mg tablet of tranexamic acid, a potent antifibrinolytic used to prevent and treat various types of bleeding. Manufactured by ACME Laboratories Ltd, Tracid 500 is especially effective in situations where blood clotting is necessary to prevent or reduce hemorrhage, such as heavy menstrual bleeding, postoperative bleeding, and hereditary angioedema.

Benefits
Tracid 500 offers substantial benefits in controlling excessive bleeding by stabilizing blood clots. Its efficacy is due to its antifibrinolytic properties, which inhibit plasminogen activation, preventing the breakdown of fibrin clots essential in many surgical and medical conditions. It has a longer-lasting effect compared to standard hemostatic medications.

Ingredients
Each tablet of Tracid 500 contains 500 mg of tranexamic acid as its active ingredient. This ingredient is responsible for its antifibrinolytic and antihemorrhagic properties.

Uses and Doses
Tracid 500 is indicated for the treatment of various types of bleeding such as heavy menstrual bleeding, nosebleeds, bleeding from surgical procedures, and bleeding due to hereditary angioedema. Adults typically take 500-1000 mg three times daily, while children are dosed based on body weight. Elderly patients and those with kidney impairment may require adjusted dosages.

Side Effects
Common side effects include nasal congestion, muscle and joint pain, and tiredness. Less common effects may involve headaches, stomach discomfort, and rare instances of postural hypotension. Patients should discontinue use if hypersensitivity occurs.

How to Use
Tracid 500 should be taken as directed by a physician, usually with food. The tablet must be swallowed whole without chewing, crushing, or breaking it.

Pregnancy & Lactation
Use of Tracid 500 during pregnancy is not recommended due to unknown effects on fetal development. Small amounts may pass into breast milk, but this is unlikely to have a significant antifibrinolytic impact on infants.

Precautions and Warnings
Patients should use Tracid 500 with caution if there is a history of renal impairment, thromboembolic disorders, or hematuria. Dosage adjustments may be necessary in patients with renal insufficiency. Vision should be monitored during prolonged use, and treatment discontinued if vision disturbances develop.

Safety Information
Tracid 500 should not be mixed with penicillin or administered with thrombolytic drugs. Concurrent use of estrogen-containing medications may increase the risk of blood clots. Patients should follow the prescribed dosage and avoid alcohol to prevent excessive drowsiness.

Indications
Tracid 500 is prescribed for various bleeding conditions, including hemophilia, digestive hemorrhages, hemorrhagic syndromes, and hemorrhage related to postpartum or surgical situations.

Pharmacology
Tranexamic acid functions as an antifibrinolytic by competitively inhibiting plasminogen activation. This stops fibrin clots from dissolving, making it effective in controlling bleeding without impacting coagulation processes.

Therapeutic Class
Hemostatic medications, anti-fibrinolytic drugs.

Storage Conditions
Store Tracid 500 in a cool, dry place at 15-30°C, away from light and out of reach of children.

3 FAQ

1. What is Tracid 500 used for?
   It is used to prevent or reduce bleeding in various medical conditions, including surgery, heavy menstrual periods, and hereditary angioedema.
2. Are there any dietary restrictions while using Tracid 500?
   Avoid alcohol to prevent excessive drowsiness. Taking it with food is recommended to reduce stomach discomfort.
3. What should I do if I miss a dose?
   Skip the missed dose if it’s almost time for the next one. Do not double the dose.

Disclaimer
This is a prescription-only medication. Use only under medical supervision. The information provided here is not a substitute for professional medical advice.

Keywords: Tracid 500, Tranexamic Acid, anti-fibrinolytic, hemostatic, bleeding control, hemorrhage treatment, ACME Laboratories, heavy periods, epistaxis, menorrhagia, hemophilia, postpartum bleeding, prostatic surgery, preventive treatment, antihemorrhagic therapy, plasminogen inhibition, nosebleeds, gastrointestinal bleeding, IUD bleeding, antifibrinolytic medicine